Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2026-04-30 @ 6:45 AM
Study NCT ID:
NCT05359432
Status:
COMPLETED
Last Update Posted:
2022-05-03
First Post:
2022-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus
Sponsor:
Getz Pharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AK_01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None